CE MARKING Sample Clauses

CE MARKING. 4.1 XDx hereby warrants and confirms that:
AutoNDA by SimpleDocs
CE MARKING. As Corgenix has the capability and know-how to provide CE-Marking services, BG Medicine, in its sole discretion, may or may not request of Corgenix that such CE Marking services be provided. If BG Medicine requests these CE Marking services of Corgenix, then, in consideration for the payment set forth in Exhibit F, Corgenix shall use all commercially reasonable efforts to obtain CE Marking certification for any and all Products by performing the tasks as set forth in Exhibit F, which Corgenix shall use all commercially reasonable efforts to complete within two weeks following completion of all tasks required to create the Technical File for Product. To the extent full services for CE Marking are not requested, the fees will be adjusted accordingly. Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 406 of the Securities Act of 1933, as amended.
CE MARKING. Seller Covenants that all goods conform with applicable Conformité Européenne (“CE”) directives for goods intended for use in the EU, including those regarding electrical/electronic devices, machinery and pressure vessels/equipment. Seller will affix the CE xxxx on goods as required. Seller will provide all documentation required by the applicable CE directives, including, but not limited to, Declarations of Conformity, Declarations of Incorporation, technical files and any documentation regarding interpretations of limitations or exclusions.
CE MARKING. Offered and delivered equipment or goods have to be compliant with Polish and European Union law requirements defined in the relevant directives or regulations, concerning the CE (Conformité Européenne) marking. All documentation as required by law shall be available in Polish. Buyer requires full support during process of risk assessment and certification of group of machines, where applicable.
CE MARKING. Equipment designed for rated voltages between 50 and 1000 V AC, or between 75 and 1500 V DC, shall have the CE marking affixed as a confirmation of the equipment fulfilling the safety requirements in section 4 and all relevant requirements in other regulations requiring CE marking of equipment. Equipment designed for rated voltage outside the voltage range specified in the first paragraph, shall have the CE marking affixed if the equipment fulfil all relevant requirements in other regulations requiring CE marking of the equipment. The CE marking shall be affixed to each single specimen of the equipment. The manufacturer or his authorized representative established within the EEA shall affix the CE marking which must be clearly visible, easy readable and durable. If it is not possible to affix the CE marking on the equipment itself, the CE making can be affixed to its packaging, the user documentation or the guarantee certificate. It is not allowed to affix marking on the equipment, its packaging, user documentation or guarantee certificate that can be mistaken for the CE marking or that may be misleading with respect to the meaning and form of the CE marking. All other marking can be affixed to the equipment, its packaging, user documentation or guarantee certificate on the condition that it will not make the CE marking less visible or more difficult to read. The CE marking is reproduced in figure 1 of Regulations 20 June 2000 no. 628 on EEA requirements related to radio equipment and telecommunications terminal equipment.
CE MARKING. In addition, Supplier agrees to add any other identification which might be requested in writing by Company. Charges, if any for such additional identification marking shall be as agreed upon by Supplier and Company prior to the implementation of any change. This Section does not reduce or modify Supplier's obligations under Section 26 IDENTIFICATION.

Related to CE MARKING

  • Patent Markings Licensee agrees that all Licensed Products Sold by Licensee, Affiliates, and Sublicensees will be marked in accordance with each country’s patent marking laws, including Title 35, U.S. Code, in the United States.

  • Marking Shipments, shipping containers and palletized unit loads shall be marked in accordance with MIL- STD-129R with Change 1 dated 24 May 2018.

  • Markings 2.8.1. Every hose shall bear, at intervals of not greater than 0.5 m, the following clearly legible and indelible identification markings consisting of characters, figures or symbols.

  • Marketing Materials (a) During the term of this Agreement, the Sub-Adviser agrees to furnish the Manager at its principal office for prior review and approval by the Manager all written and/or printed materials, including but not limited to, PowerPointÒ or slide presentations, news releases, advertisements, brochures, fact sheets and other promotional, informational or marketing materials (the “Marketing Materials”) for internal use or public dissemination, that are produced or are for use or reference by the Sub-Adviser, its affiliates or other designees, broker-dealers or the public in connection with the Series, and Sub-Adviser shall not use any such materials if the Manager reasonably objects in writing within five business days (or such other period as may be mutually agreed) after receipt thereof. Marketing Materials may be furnished to the Manager by first class or overnight mail, facsimile transmission equipment, electronic delivery or hand delivery.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

Time is Money Join Law Insider Premium to draft better contracts faster.